nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—FPGS—Metabolism of folate and pterines—MTHFR—uterine cancer	0.0358	0.138	CbGpPWpGaD
Raltitrexed—FPGS—myometrium—uterine cancer	0.0252	0.12	CbGeAlD
Raltitrexed—FPGS—Fluoropyrimidine Activity—RRM2—uterine cancer	0.0251	0.0967	CbGpPWpGaD
Raltitrexed—FPGS—decidua—uterine cancer	0.0187	0.0891	CbGeAlD
Raltitrexed—FPGS—endometrium—uterine cancer	0.0177	0.0846	CbGeAlD
Raltitrexed—FPGS—mammalian vulva—uterine cancer	0.0172	0.0818	CbGeAlD
Raltitrexed—Extravasation—Carboplatin—uterine cancer	0.0158	0.0316	CcSEcCtD
Raltitrexed—TYMS—G1/S-Specific Transcription—RRM2—uterine cancer	0.0155	0.0599	CbGpPWpGaD
Raltitrexed—FPGS—female reproductive system—uterine cancer	0.0147	0.0701	CbGeAlD
Raltitrexed—FPGS—female gonad—uterine cancer	0.0134	0.0638	CbGeAlD
Raltitrexed—FPGS—vagina—uterine cancer	0.0133	0.0634	CbGeAlD
Raltitrexed—TYMS—uterine cervix—uterine cancer	0.0129	0.0613	CbGeAlD
Raltitrexed—FPGS—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.0127	0.0489	CbGpPWpGaD
Raltitrexed—TYMS—smooth muscle tissue—uterine cancer	0.0125	0.0596	CbGeAlD
Raltitrexed—TYMS—endometrium—uterine cancer	0.0116	0.0555	CbGeAlD
Raltitrexed—TYMS—mammalian vulva—uterine cancer	0.0113	0.0537	CbGeAlD
Raltitrexed—Influenza-like symptoms—Progesterone—uterine cancer	0.0101	0.0202	CcSEcCtD
Raltitrexed—Supraventricular tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00999	0.02	CcSEcCtD
Raltitrexed—TYMS—female reproductive system—uterine cancer	0.00963	0.046	CbGeAlD
Raltitrexed—TYMS—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00914	0.0353	CbGpPWpGaD
Raltitrexed—TYMS—E2F mediated regulation of DNA replication—RRM2—uterine cancer	0.00914	0.0353	CbGpPWpGaD
Raltitrexed—TYMS—female gonad—uterine cancer	0.00877	0.0418	CbGeAlD
Raltitrexed—TYMS—vagina—uterine cancer	0.00871	0.0416	CbGeAlD
Raltitrexed—FPGS—lymph node—uterine cancer	0.00859	0.041	CbGeAlD
Raltitrexed—Febrile neutropenia—Dactinomycin—uterine cancer	0.00849	0.017	CcSEcCtD
Raltitrexed—Necrosis—Medroxyprogesterone Acetate—uterine cancer	0.00834	0.0167	CcSEcCtD
Raltitrexed—TYMS—Podofilox—Etoposide—uterine cancer	0.00816	0.531	CbGdCrCtD
Raltitrexed—Influenza like illness—Progesterone—uterine cancer	0.00702	0.014	CcSEcCtD
Raltitrexed—Necrosis—Dactinomycin—uterine cancer	0.00651	0.013	CcSEcCtD
Raltitrexed—Hypertonia—Progesterone—uterine cancer	0.00633	0.0127	CcSEcCtD
Raltitrexed—Febrile neutropenia—Etoposide—uterine cancer	0.00614	0.0123	CcSEcCtD
Raltitrexed—Folic Acid—MTHFR—uterine cancer	0.00605	0.373	CrCbGaD
Raltitrexed—Tetrahydrofolic acid—MTHFR—uterine cancer	0.00605	0.373	CrCbGaD
Raltitrexed—Mouth ulceration—Medroxyprogesterone Acetate—uterine cancer	0.00592	0.0118	CcSEcCtD
Raltitrexed—Extravasation—Dactinomycin—uterine cancer	0.00585	0.0117	CcSEcCtD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.00584	0.0225	CbGpPWpGaD
Raltitrexed—Hepatic failure—Progesterone—uterine cancer	0.00584	0.0117	CcSEcCtD
Raltitrexed—Sepsis—Medroxyprogesterone Acetate—uterine cancer	0.00568	0.0114	CcSEcCtD
Raltitrexed—TYMS—lymph node—uterine cancer	0.00564	0.0269	CbGeAlD
Raltitrexed—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00529	0.0106	CcSEcCtD
Raltitrexed—TYMS—One Carbon Metabolism—MTHFR—uterine cancer	0.00527	0.0203	CbGpPWpGaD
Raltitrexed—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.00524	0.0105	CcSEcCtD
Raltitrexed—Sinus tachycardia—Epirubicin—uterine cancer	0.00514	0.0103	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00511	0.0197	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.005	0.0193	CbGpPWpGaD
Raltitrexed—Infection—Carboplatin—uterine cancer	0.00488	0.00976	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—RRM2—uterine cancer	0.00484	0.0187	CbGpPWpGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TP53—uterine cancer	0.00481	0.0186	CbGpPWpGaD
Raltitrexed—Sinus tachycardia—Doxorubicin—uterine cancer	0.00476	0.00953	CcSEcCtD
Raltitrexed—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—uterine cancer	0.00474	0.0183	CbGpPWpGaD
Raltitrexed—Necrosis—Etoposide—uterine cancer	0.00471	0.00943	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00462	0.0178	CbGpPWpGaD
Raltitrexed—Mouth ulceration—Dactinomycin—uterine cancer	0.00462	0.00924	CcSEcCtD
Raltitrexed—TYMS—Nucleotide metabolism—RRM2—uterine cancer	0.00459	0.0177	CbGpPWpGaD
Raltitrexed—Sepsis—Dactinomycin—uterine cancer	0.00443	0.00887	CcSEcCtD
Raltitrexed—Extravasation—Etoposide—uterine cancer	0.00424	0.00848	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00421	0.0162	CbGpPWpGaD
Raltitrexed—TYMS—Danazol—Progesterone—uterine cancer	0.0042	0.273	CbGdCrCtD
Raltitrexed—Pain—Carboplatin—uterine cancer	0.0042	0.0084	CcSEcCtD
Raltitrexed—Methotrexate—MTHFR—uterine cancer	0.00414	0.255	CrCbGaD
Raltitrexed—Hepatic failure—Dactinomycin—uterine cancer	0.00413	0.00826	CcSEcCtD
Raltitrexed—Weight decreased—Progesterone—uterine cancer	0.0041	0.00821	CcSEcCtD
Raltitrexed—Cellulitis—Etoposide—uterine cancer	0.00406	0.00814	CcSEcCtD
Raltitrexed—Conjunctivitis—Progesterone—uterine cancer	0.00393	0.00786	CcSEcCtD
Raltitrexed—Body temperature increased—Carboplatin—uterine cancer	0.00388	0.00777	CcSEcCtD
Raltitrexed—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.00744	CcSEcCtD
Raltitrexed—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00357	0.00715	CcSEcCtD
Raltitrexed—Skin exfoliation—Etoposide—uterine cancer	0.00353	0.00706	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—RRM2—uterine cancer	0.00351	0.0136	CbGpPWpGaD
Raltitrexed—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00351	0.00703	CcSEcCtD
Raltitrexed—Febrile neutropenia—Epirubicin—uterine cancer	0.00344	0.00689	CcSEcCtD
Raltitrexed—Mouth ulceration—Etoposide—uterine cancer	0.00334	0.00669	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—STAR—uterine cancer	0.00329	0.0127	CbGpPWpGaD
Raltitrexed—Sepsis—Etoposide—uterine cancer	0.00321	0.00642	CcSEcCtD
Raltitrexed—Alopecia—Progesterone—uterine cancer	0.00321	0.00642	CcSEcCtD
Raltitrexed—Febrile neutropenia—Doxorubicin—uterine cancer	0.00319	0.00638	CcSEcCtD
Raltitrexed—TYMS—Levonorgestrel—Progesterone—uterine cancer	0.00301	0.196	CbGdCrCtD
Raltitrexed—Neutropenia—Dactinomycin—uterine cancer	0.003	0.006	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.00296	0.0114	CbGpPWpGaD
Raltitrexed—Cardiac failure congestive—Etoposide—uterine cancer	0.00296	0.00592	CcSEcCtD
Raltitrexed—Ill-defined disorder—Progesterone—uterine cancer	0.00293	0.00587	CcSEcCtD
Raltitrexed—Anaemia—Progesterone—uterine cancer	0.00292	0.00584	CcSEcCtD
Raltitrexed—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00291	0.00582	CcSEcCtD
Raltitrexed—Malaise—Progesterone—uterine cancer	0.00285	0.0057	CcSEcCtD
Raltitrexed—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.0028	0.00561	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00279	0.0108	CbGpPWpGaD
Raltitrexed—Stomatitis—Dactinomycin—uterine cancer	0.00278	0.00557	CcSEcCtD
Raltitrexed—Cough—Progesterone—uterine cancer	0.00276	0.00552	CcSEcCtD
Raltitrexed—Arthralgia—Progesterone—uterine cancer	0.00269	0.00538	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—HNF1B—uterine cancer	0.00268	0.0104	CbGpPWpGaD
Raltitrexed—Discomfort—Progesterone—uterine cancer	0.00266	0.00532	CcSEcCtD
Raltitrexed—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00266	0.00532	CcSEcCtD
Raltitrexed—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.0053	CcSEcCtD
Raltitrexed—Necrosis—Epirubicin—uterine cancer	0.00264	0.00528	CcSEcCtD
Raltitrexed—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00517	CcSEcCtD
Raltitrexed—Oedema—Progesterone—uterine cancer	0.00258	0.00516	CcSEcCtD
Raltitrexed—Infection—Progesterone—uterine cancer	0.00256	0.00513	CcSEcCtD
Raltitrexed—Hyperhidrosis—Progesterone—uterine cancer	0.00249	0.00499	CcSEcCtD
Raltitrexed—Anorexia—Progesterone—uterine cancer	0.00246	0.00492	CcSEcCtD
Raltitrexed—Necrosis—Doxorubicin—uterine cancer	0.00244	0.00489	CcSEcCtD
Raltitrexed—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.00488	CcSEcCtD
Raltitrexed—FPGS—Metabolism—NDUFB11—uterine cancer	0.00242	0.00934	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—SRD5A2—uterine cancer	0.00242	0.00934	CbGpPWpGaD
Raltitrexed—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00482	CcSEcCtD
Raltitrexed—Extravasation—Epirubicin—uterine cancer	0.00237	0.00475	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00235	0.0047	CcSEcCtD
Raltitrexed—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00468	CcSEcCtD
Raltitrexed—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00465	CcSEcCtD
Raltitrexed—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00229	0.00458	CcSEcCtD
Raltitrexed—Cellulitis—Epirubicin—uterine cancer	0.00228	0.00456	CcSEcCtD
Raltitrexed—Dyspepsia—Progesterone—uterine cancer	0.00227	0.00454	CcSEcCtD
Raltitrexed—Alopecia—Dactinomycin—uterine cancer	0.00227	0.00454	CcSEcCtD
Raltitrexed—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00452	CcSEcCtD
Raltitrexed—FPGS—Disease—AKR1B10—uterine cancer	0.00225	0.00867	CbGpPWpGaD
Raltitrexed—Decreased appetite—Progesterone—uterine cancer	0.00224	0.00449	CcSEcCtD
Raltitrexed—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.00446	CcSEcCtD
Raltitrexed—Pain—Progesterone—uterine cancer	0.0022	0.00441	CcSEcCtD
Raltitrexed—Constipation—Progesterone—uterine cancer	0.0022	0.00441	CcSEcCtD
Raltitrexed—Extravasation—Doxorubicin—uterine cancer	0.0022	0.0044	CcSEcCtD
Raltitrexed—Neutropenia—Etoposide—uterine cancer	0.00217	0.00434	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00426	CcSEcCtD
Raltitrexed—Feeling abnormal—Progesterone—uterine cancer	0.00212	0.00425	CcSEcCtD
Raltitrexed—Cellulitis—Doxorubicin—uterine cancer	0.00211	0.00422	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Progesterone—uterine cancer	0.00211	0.00422	CcSEcCtD
Raltitrexed—Ill-defined disorder—Dactinomycin—uterine cancer	0.00207	0.00415	CcSEcCtD
Raltitrexed—Anaemia—Dactinomycin—uterine cancer	0.00206	0.00413	CcSEcCtD
Raltitrexed—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00412	CcSEcCtD
Raltitrexed—Abdominal pain—Progesterone—uterine cancer	0.00204	0.00408	CcSEcCtD
Raltitrexed—Body temperature increased—Progesterone—uterine cancer	0.00204	0.00408	CcSEcCtD
Raltitrexed—Renal failure—Etoposide—uterine cancer	0.00203	0.00407	CcSEcCtD
Raltitrexed—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00406	CcSEcCtD
Raltitrexed—Stomatitis—Etoposide—uterine cancer	0.00202	0.00403	CcSEcCtD
Raltitrexed—Malaise—Dactinomycin—uterine cancer	0.00201	0.00403	CcSEcCtD
Raltitrexed—Influenza like illness—Epirubicin—uterine cancer	0.00201	0.00403	CcSEcCtD
Raltitrexed—Leukopenia—Dactinomycin—uterine cancer	0.002	0.004	CcSEcCtD
Raltitrexed—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.002	0.004	CcSEcCtD
Raltitrexed—Skin exfoliation—Epirubicin—uterine cancer	0.00198	0.00396	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—MLH3—uterine cancer	0.00196	0.00756	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.00385	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00382	CcSEcCtD
Raltitrexed—Discomfort—Dactinomycin—uterine cancer	0.00188	0.00376	CcSEcCtD
Raltitrexed—Mouth ulceration—Epirubicin—uterine cancer	0.00187	0.00375	CcSEcCtD
Raltitrexed—Influenza like illness—Doxorubicin—uterine cancer	0.00186	0.00373	CcSEcCtD
Raltitrexed—FPGS—Disease—RNF43—uterine cancer	0.00186	0.00718	CbGpPWpGaD
Raltitrexed—Asthenia—Progesterone—uterine cancer	0.00185	0.0037	CcSEcCtD
Raltitrexed—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.0037	CcSEcCtD
Raltitrexed—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.0037	CcSEcCtD
Raltitrexed—Skin exfoliation—Doxorubicin—uterine cancer	0.00183	0.00366	CcSEcCtD
Raltitrexed—Pruritus—Progesterone—uterine cancer	0.00182	0.00365	CcSEcCtD
Raltitrexed—Oedema—Dactinomycin—uterine cancer	0.00182	0.00365	CcSEcCtD
Raltitrexed—Hypertonia—Epirubicin—uterine cancer	0.00182	0.00364	CcSEcCtD
Raltitrexed—Infection—Dactinomycin—uterine cancer	0.00181	0.00362	CcSEcCtD
Raltitrexed—Sepsis—Epirubicin—uterine cancer	0.0018	0.0036	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00179	0.00692	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.00179	0.00689	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Dactinomycin—uterine cancer	0.00178	0.00357	CcSEcCtD
Raltitrexed—Diarrhoea—Progesterone—uterine cancer	0.00176	0.00353	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—uterine cancer	0.00175	0.00677	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKR1B1—uterine cancer	0.00175	0.00675	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—STAR—uterine cancer	0.00175	0.00675	CbGpPWpGaD
Raltitrexed—Anorexia—Dactinomycin—uterine cancer	0.00174	0.00348	CcSEcCtD
Raltitrexed—Mouth ulceration—Doxorubicin—uterine cancer	0.00173	0.00347	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—EZH2—uterine cancer	0.00172	0.00664	CbGpPWpGaD
Raltitrexed—Hypertonia—Doxorubicin—uterine cancer	0.00168	0.00336	CcSEcCtD
Raltitrexed—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00335	CcSEcCtD
Raltitrexed—Hepatic failure—Epirubicin—uterine cancer	0.00167	0.00335	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—CDKN2A—uterine cancer	0.00167	0.00644	CbGpPWpGaD
Raltitrexed—Sepsis—Doxorubicin—uterine cancer	0.00166	0.00333	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00166	0.00641	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00166	0.00332	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Epirubicin—uterine cancer	0.00166	0.00332	CcSEcCtD
Raltitrexed—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00331	CcSEcCtD
Raltitrexed—Alopecia—Etoposide—uterine cancer	0.00164	0.00328	CcSEcCtD
Raltitrexed—Vomiting—Progesterone—uterine cancer	0.00164	0.00328	CcSEcCtD
Raltitrexed—Rash—Progesterone—uterine cancer	0.00163	0.00325	CcSEcCtD
Raltitrexed—Dermatitis—Progesterone—uterine cancer	0.00162	0.00325	CcSEcCtD
Raltitrexed—Headache—Progesterone—uterine cancer	0.00161	0.00323	CcSEcCtD
Raltitrexed—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.0032	CcSEcCtD
Raltitrexed—Decreased appetite—Dactinomycin—uterine cancer	0.00158	0.00317	CcSEcCtD
Raltitrexed—Dysgeusia—Etoposide—uterine cancer	0.00158	0.00317	CcSEcCtD
Raltitrexed—Renal impairment—Epirubicin—uterine cancer	0.00158	0.00316	CcSEcCtD
Raltitrexed—Pain—Dactinomycin—uterine cancer	0.00156	0.00312	CcSEcCtD
Raltitrexed—Hepatic failure—Doxorubicin—uterine cancer	0.00155	0.0031	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00153	0.00307	CcSEcCtD
Raltitrexed—FPGS—Disease—AKR1C1—uterine cancer	0.00153	0.00592	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—NDC80—uterine cancer	0.00153	0.00591	CbGpPWpGaD
Raltitrexed—Nausea—Progesterone—uterine cancer	0.00153	0.00306	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00151	0.00582	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Dactinomycin—uterine cancer	0.0015	0.00301	CcSEcCtD
Raltitrexed—Ill-defined disorder—Etoposide—uterine cancer	0.0015	0.003	CcSEcCtD
Raltitrexed—Anaemia—Etoposide—uterine cancer	0.00149	0.00299	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00149	0.00298	CcSEcCtD
Raltitrexed—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00297	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—CDKN1B—uterine cancer	0.00148	0.00571	CbGpPWpGaD
Raltitrexed—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00295	CcSEcCtD
Raltitrexed—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00295	CcSEcCtD
Raltitrexed—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00293	CcSEcCtD
Raltitrexed—Renal impairment—Doxorubicin—uterine cancer	0.00146	0.00293	CcSEcCtD
Raltitrexed—Malaise—Etoposide—uterine cancer	0.00146	0.00292	CcSEcCtD
Raltitrexed—Leukopenia—Etoposide—uterine cancer	0.00145	0.0029	CcSEcCtD
Raltitrexed—Body temperature increased—Dactinomycin—uterine cancer	0.00144	0.00288	CcSEcCtD
Raltitrexed—Abdominal pain—Dactinomycin—uterine cancer	0.00144	0.00288	CcSEcCtD
Raltitrexed—Cough—Etoposide—uterine cancer	0.00141	0.00282	CcSEcCtD
Raltitrexed—Dehydration—Epirubicin—uterine cancer	0.0014	0.0028	CcSEcCtD
Raltitrexed—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00278	CcSEcCtD
Raltitrexed—FPGS—Metabolism—POLD1—uterine cancer	0.00137	0.0053	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—NDC80—uterine cancer	0.00137	0.00528	CbGpPWpGaD
Raltitrexed—Discomfort—Etoposide—uterine cancer	0.00136	0.00272	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.00135	0.00522	CbGpPWpGaD
Raltitrexed—FPGS—Disease—DCN—uterine cancer	0.00133	0.00512	CbGpPWpGaD
Raltitrexed—Infection—Etoposide—uterine cancer	0.00131	0.00262	CcSEcCtD
Raltitrexed—Asthenia—Dactinomycin—uterine cancer	0.00131	0.00262	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—POLD1—uterine cancer	0.0013	0.00503	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—EP300—uterine cancer	0.0013	0.00501	CbGpPWpGaD
Raltitrexed—Dehydration—Doxorubicin—uterine cancer	0.00129	0.00259	CcSEcCtD
Raltitrexed—Thrombocytopenia—Etoposide—uterine cancer	0.00129	0.00258	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.00129	0.00496	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKR1C1—uterine cancer	0.00128	0.00495	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Etoposide—uterine cancer	0.00127	0.00255	CcSEcCtD
Raltitrexed—Anorexia—Etoposide—uterine cancer	0.00126	0.00252	CcSEcCtD
Raltitrexed—Diarrhoea—Dactinomycin—uterine cancer	0.00125	0.0025	CcSEcCtD
Raltitrexed—Neutropenia—Epirubicin—uterine cancer	0.00122	0.00243	CcSEcCtD
Raltitrexed—FPGS—Disease—AKR1C3—uterine cancer	0.00118	0.00455	CbGpPWpGaD
Raltitrexed—Weight decreased—Epirubicin—uterine cancer	0.00118	0.00235	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—POLD1—uterine cancer	0.00116	0.00449	CbGpPWpGaD
Raltitrexed—Vomiting—Dactinomycin—uterine cancer	0.00116	0.00232	CcSEcCtD
Raltitrexed—FPGS—Disease—HMGA1—uterine cancer	0.00115	0.00444	CbGpPWpGaD
Raltitrexed—Rash—Dactinomycin—uterine cancer	0.00115	0.0023	CcSEcCtD
Raltitrexed—Decreased appetite—Etoposide—uterine cancer	0.00115	0.00229	CcSEcCtD
Raltitrexed—FPGS—Metabolism—RRM2—uterine cancer	0.00114	0.00442	CbGpPWpGaD
Raltitrexed—Renal failure—Epirubicin—uterine cancer	0.00114	0.00228	CcSEcCtD
Raltitrexed—Stomatitis—Epirubicin—uterine cancer	0.00113	0.00226	CcSEcCtD
Raltitrexed—Pain—Etoposide—uterine cancer	0.00113	0.00226	CcSEcCtD
Raltitrexed—Constipation—Etoposide—uterine cancer	0.00113	0.00226	CcSEcCtD
Raltitrexed—Conjunctivitis—Epirubicin—uterine cancer	0.00113	0.00226	CcSEcCtD
Raltitrexed—Neutropenia—Doxorubicin—uterine cancer	0.00112	0.00225	CcSEcCtD
Raltitrexed—Sweating—Epirubicin—uterine cancer	0.00111	0.00222	CcSEcCtD
Raltitrexed—FPGS—Metabolism—DCN—uterine cancer	0.00111	0.00429	CbGpPWpGaD
Raltitrexed—Weight decreased—Doxorubicin—uterine cancer	0.00109	0.00218	CcSEcCtD
Raltitrexed—Feeling abnormal—Etoposide—uterine cancer	0.00109	0.00218	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RRM2—uterine cancer	0.00109	0.00419	CbGpPWpGaD
Raltitrexed—Nausea—Dactinomycin—uterine cancer	0.00108	0.00217	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Etoposide—uterine cancer	0.00108	0.00216	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—CDKN1B—uterine cancer	0.00107	0.00414	CbGpPWpGaD
Raltitrexed—Renal failure—Doxorubicin—uterine cancer	0.00105	0.00211	CcSEcCtD
Raltitrexed—FPGS—Disease—FBXW7—uterine cancer	0.00105	0.00406	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP11A1—uterine cancer	0.00105	0.00404	CbGpPWpGaD
Raltitrexed—Stomatitis—Doxorubicin—uterine cancer	0.00105	0.00209	CcSEcCtD
Raltitrexed—Abdominal pain—Etoposide—uterine cancer	0.00104	0.00209	CcSEcCtD
Raltitrexed—Body temperature increased—Etoposide—uterine cancer	0.00104	0.00209	CcSEcCtD
Raltitrexed—Conjunctivitis—Doxorubicin—uterine cancer	0.00104	0.00209	CcSEcCtD
Raltitrexed—Sweating—Doxorubicin—uterine cancer	0.00103	0.00206	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.00102	0.00394	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.00101	0.00389	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKR1C3—uterine cancer	0.000988	0.00381	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RRM2—uterine cancer	0.000971	0.00375	CbGpPWpGaD
Raltitrexed—Asthenia—Etoposide—uterine cancer	0.000946	0.00189	CcSEcCtD
Raltitrexed—Pruritus—Etoposide—uterine cancer	0.000933	0.00187	CcSEcCtD
Raltitrexed—Arrhythmia—Epirubicin—uterine cancer	0.000929	0.00186	CcSEcCtD
Raltitrexed—Alopecia—Epirubicin—uterine cancer	0.000919	0.00184	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000904	0.00349	CbGpPWpGaD
Raltitrexed—Diarrhoea—Etoposide—uterine cancer	0.000902	0.00181	CcSEcCtD
Raltitrexed—Dysgeusia—Epirubicin—uterine cancer	0.000887	0.00178	CcSEcCtD
Raltitrexed—TYMS—Metabolism—SRD5A2—uterine cancer	0.000882	0.0034	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NDUFB11—uterine cancer	0.000882	0.0034	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000872	0.00336	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MLH1—uterine cancer	0.000862	0.00333	CbGpPWpGaD
Raltitrexed—Arrhythmia—Doxorubicin—uterine cancer	0.00086	0.00172	CcSEcCtD
Raltitrexed—Alopecia—Doxorubicin—uterine cancer	0.000851	0.0017	CcSEcCtD
Raltitrexed—Ill-defined disorder—Epirubicin—uterine cancer	0.00084	0.00168	CcSEcCtD
Raltitrexed—Vomiting—Etoposide—uterine cancer	0.000838	0.00168	CcSEcCtD
Raltitrexed—Anaemia—Epirubicin—uterine cancer	0.000837	0.00168	CcSEcCtD
Raltitrexed—Rash—Etoposide—uterine cancer	0.000831	0.00166	CcSEcCtD
Raltitrexed—Dermatitis—Etoposide—uterine cancer	0.000831	0.00166	CcSEcCtD
Raltitrexed—Headache—Etoposide—uterine cancer	0.000826	0.00165	CcSEcCtD
Raltitrexed—FPGS—Disease—CDKN2B—uterine cancer	0.000824	0.00318	CbGpPWpGaD
Raltitrexed—Dysgeusia—Doxorubicin—uterine cancer	0.000821	0.00164	CcSEcCtD
Raltitrexed—Malaise—Epirubicin—uterine cancer	0.000817	0.00163	CcSEcCtD
Raltitrexed—Leukopenia—Epirubicin—uterine cancer	0.000811	0.00162	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000808	0.00312	CbGpPWpGaD
Raltitrexed—Cough—Epirubicin—uterine cancer	0.00079	0.00158	CcSEcCtD
Raltitrexed—Nausea—Etoposide—uterine cancer	0.000783	0.00157	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—YWHAE—uterine cancer	0.00078	0.00301	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Doxorubicin—uterine cancer	0.000778	0.00156	CcSEcCtD
Raltitrexed—Anaemia—Doxorubicin—uterine cancer	0.000775	0.00155	CcSEcCtD
Raltitrexed—Arthralgia—Epirubicin—uterine cancer	0.000771	0.00154	CcSEcCtD
Raltitrexed—FPGS—Metabolism—STK11—uterine cancer	0.00077	0.00297	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP19A1—uterine cancer	0.00077	0.00297	CbGpPWpGaD
Raltitrexed—Discomfort—Epirubicin—uterine cancer	0.000762	0.00152	CcSEcCtD
Raltitrexed—Malaise—Doxorubicin—uterine cancer	0.000756	0.00151	CcSEcCtD
Raltitrexed—FPGS—Disease—SMAD3—uterine cancer	0.000753	0.0029	CbGpPWpGaD
Raltitrexed—Leukopenia—Doxorubicin—uterine cancer	0.00075	0.0015	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.00074	0.00285	CbGpPWpGaD
Raltitrexed—Oedema—Epirubicin—uterine cancer	0.000739	0.00148	CcSEcCtD
Raltitrexed—Infection—Epirubicin—uterine cancer	0.000734	0.00147	CcSEcCtD
Raltitrexed—Cough—Doxorubicin—uterine cancer	0.000731	0.00146	CcSEcCtD
Raltitrexed—Thrombocytopenia—Epirubicin—uterine cancer	0.000724	0.00145	CcSEcCtD
Raltitrexed—FPGS—Disease—FGFR2—uterine cancer	0.000718	0.00277	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Epirubicin—uterine cancer	0.000715	0.00143	CcSEcCtD
Raltitrexed—Arthralgia—Doxorubicin—uterine cancer	0.000713	0.00143	CcSEcCtD
Raltitrexed—Discomfort—Doxorubicin—uterine cancer	0.000705	0.00141	CcSEcCtD
Raltitrexed—Anorexia—Epirubicin—uterine cancer	0.000705	0.00141	CcSEcCtD
Raltitrexed—FPGS—Disease—MTHFR—uterine cancer	0.000691	0.00267	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000685	0.00264	CbGpPWpGaD
Raltitrexed—Oedema—Doxorubicin—uterine cancer	0.000684	0.00137	CcSEcCtD
Raltitrexed—Infection—Doxorubicin—uterine cancer	0.000679	0.00136	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000673	0.00135	CcSEcCtD
Raltitrexed—Thrombocytopenia—Doxorubicin—uterine cancer	0.00067	0.00134	CcSEcCtD
Raltitrexed—Hyperhidrosis—Doxorubicin—uterine cancer	0.000661	0.00132	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000655	0.00253	CbGpPWpGaD
Raltitrexed—Anorexia—Doxorubicin—uterine cancer	0.000652	0.00131	CcSEcCtD
Raltitrexed—Dyspepsia—Epirubicin—uterine cancer	0.000651	0.0013	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000647	0.0025	CbGpPWpGaD
Raltitrexed—Decreased appetite—Epirubicin—uterine cancer	0.000643	0.00129	CcSEcCtD
Raltitrexed—TYMS—Metabolism—STAR—uterine cancer	0.000638	0.00246	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKR1B1—uterine cancer	0.000638	0.00246	CbGpPWpGaD
Raltitrexed—Constipation—Epirubicin—uterine cancer	0.000632	0.00127	CcSEcCtD
Raltitrexed—Pain—Epirubicin—uterine cancer	0.000632	0.00127	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000631	0.00243	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000623	0.00125	CcSEcCtD
Raltitrexed—Feeling abnormal—Epirubicin—uterine cancer	0.000609	0.00122	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—PTEN—uterine cancer	0.000606	0.00234	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Epirubicin—uterine cancer	0.000604	0.00121	CcSEcCtD
Raltitrexed—Dyspepsia—Doxorubicin—uterine cancer	0.000602	0.00121	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000602	0.00232	CbGpPWpGaD
Raltitrexed—Decreased appetite—Doxorubicin—uterine cancer	0.000595	0.00119	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDKN2B—uterine cancer	0.000586	0.00226	CbGpPWpGaD
Raltitrexed—Constipation—Doxorubicin—uterine cancer	0.000585	0.00117	CcSEcCtD
Raltitrexed—Pain—Doxorubicin—uterine cancer	0.000585	0.00117	CcSEcCtD
Raltitrexed—Body temperature increased—Epirubicin—uterine cancer	0.000584	0.00117	CcSEcCtD
Raltitrexed—Abdominal pain—Epirubicin—uterine cancer	0.000584	0.00117	CcSEcCtD
Raltitrexed—FPGS—Metabolism—MTHFR—uterine cancer	0.000579	0.00223	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—EP300—uterine cancer	0.000578	0.00223	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.00057	0.0022	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000565	0.00218	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Doxorubicin—uterine cancer	0.000564	0.00113	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000559	0.00112	CcSEcCtD
Raltitrexed—Abdominal pain—Doxorubicin—uterine cancer	0.000541	0.00108	CcSEcCtD
Raltitrexed—Body temperature increased—Doxorubicin—uterine cancer	0.000541	0.00108	CcSEcCtD
Raltitrexed—Asthenia—Epirubicin—uterine cancer	0.00053	0.00106	CcSEcCtD
Raltitrexed—Pruritus—Epirubicin—uterine cancer	0.000523	0.00105	CcSEcCtD
Raltitrexed—Diarrhoea—Epirubicin—uterine cancer	0.000506	0.00101	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—BIRC5—uterine cancer	0.000505	0.00195	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—POLD1—uterine cancer	0.0005	0.00193	CbGpPWpGaD
Raltitrexed—Asthenia—Doxorubicin—uterine cancer	0.000491	0.000982	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000484	0.00187	CbGpPWpGaD
Raltitrexed—Pruritus—Doxorubicin—uterine cancer	0.000484	0.000969	CcSEcCtD
Raltitrexed—Vomiting—Epirubicin—uterine cancer	0.00047	0.000941	CcSEcCtD
Raltitrexed—TYMS—Metabolism—AKR1C1—uterine cancer	0.000468	0.00181	CbGpPWpGaD
Raltitrexed—Diarrhoea—Doxorubicin—uterine cancer	0.000468	0.000937	CcSEcCtD
Raltitrexed—Rash—Epirubicin—uterine cancer	0.000466	0.000933	CcSEcCtD
Raltitrexed—Dermatitis—Epirubicin—uterine cancer	0.000466	0.000932	CcSEcCtD
Raltitrexed—Headache—Epirubicin—uterine cancer	0.000463	0.000927	CcSEcCtD
Raltitrexed—FPGS—Disease—ERBB2—uterine cancer	0.000451	0.00174	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000445	0.00172	CbGpPWpGaD
Raltitrexed—Nausea—Epirubicin—uterine cancer	0.000439	0.000879	CcSEcCtD
Raltitrexed—Vomiting—Doxorubicin—uterine cancer	0.000435	0.00087	CcSEcCtD
Raltitrexed—Rash—Doxorubicin—uterine cancer	0.000431	0.000863	CcSEcCtD
Raltitrexed—Dermatitis—Doxorubicin—uterine cancer	0.000431	0.000862	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000431	0.00166	CbGpPWpGaD
Raltitrexed—Headache—Doxorubicin—uterine cancer	0.000428	0.000858	CcSEcCtD
Raltitrexed—FPGS—Disease—CDKN1B—uterine cancer	0.000417	0.00161	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—RRM2—uterine cancer	0.000417	0.00161	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—uterine cancer	0.000413	0.00159	CbGpPWpGaD
Raltitrexed—Nausea—Doxorubicin—uterine cancer	0.000406	0.000813	CcSEcCtD
Raltitrexed—TYMS—Metabolism—DCN—uterine cancer	0.000405	0.00156	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CTNNB1—uterine cancer	0.000394	0.00152	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTEN—uterine cancer	0.000384	0.00148	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP11A1—uterine cancer	0.000381	0.00147	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000375	0.00145	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EP300—uterine cancer	0.000367	0.00141	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000364	0.0014	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKR1C3—uterine cancer	0.00036	0.00139	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NRAS—uterine cancer	0.000343	0.00132	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN2A—uterine cancer	0.000335	0.00129	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000332	0.00128	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTEN—uterine cancer	0.000322	0.00124	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—EP300—uterine cancer	0.000307	0.00118	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1B—uterine cancer	0.000297	0.00114	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—uterine cancer	0.000295	0.00114	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—EP300—uterine cancer	0.000291	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP19A1—uterine cancer	0.000281	0.00108	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—STK11—uterine cancer	0.000281	0.00108	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—uterine cancer	0.000271	0.00105	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—EP300—uterine cancer	0.00026	0.001	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—uterine cancer	0.000251	0.000968	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—uterine cancer	0.000227	0.000876	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—uterine cancer	0.000222	0.000855	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTHFR—uterine cancer	0.000211	0.000814	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—uterine cancer	0.000186	0.000719	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—uterine cancer	0.000186	0.000716	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTEN—uterine cancer	0.000117	0.000453	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—EP300—uterine cancer	0.000112	0.000432	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—uterine cancer	8.28e-05	0.000319	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—uterine cancer	6.76e-05	0.000261	CbGpPWpGaD
